Ribosomal Protein S6 mRNA Is a Biomarker Upregulated in Multiple Sclerosis, Downregulated by Interferon Treatment, and Affected by Season

Multiple Sclerosis - United States
doi 10.1177/1352458513507819
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

SAGE Publications

Related search

Ribosomal Protein S6 Phosphorylation Is Controlled by TOR and Modulated by PKA inCandida Albicans

Molecular Microbiology
MicrobiologyMolecular Biology
2015English

Retinal Oximetry Is Affected in Multiple Sclerosis

Acta Ophthalmologica
MedicineOphthalmology
2018English

The Ribosomal Protein S6 in Renal Cell Carcinoma: Functional Relevance and Potential as Biomarker

Oncotarget
Oncology
2015English

Treatment Recommendations for Interferon-Beta in Multiple Sclerosis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1999English

Relation Between Walking Speed and Muscle Strength Is Affected by Somatosensory Loss in Multiple Sclerosis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2002English

Ribosomal Protein S6, a Target of Rapamycin, Is Involved in the Regulation of rRNA Genes by Possible Epigenetic Changes inArabidopsis

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

Differential Requirement of the Ribosomal Protein S6 and Ribosomal Protein S6 Kinase for Plant-Virus Accumulation and Interaction of S6 Kinase With Potyviral VPg

Molecular Plant-Microbe Interactions
MedicineAgronomyCrop SciencePhysiology
2017English

AUF1 Is Upregulated by Angiotensin II to Destabilize Cardiac Kv4.3 Channel mRNA

Journal of Molecular and Cellular Cardiology
Cardiovascular MedicineMolecular BiologyCardiology
2008English

Tobacco cDNA Encoding the Ribosomal Protein S6

Nucleic Acids Research
Genetics
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy